Sevoflurane;Sevoflurano

Revista Espanola de Anestesiologia y Reanimacion

Volumn 43, Issue 7, 1996, Pages 243-248

  Gilsanz, F ^a   Celemin R ^a   Blanc, G ^a   Orts, M M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Inhalatory anesthetic, sevoflurane

Indexed keywords

INHALATION ANESTHETIC AGENT; SEVOFLURANE;

AMBULATORY SURGERY; ARTICLE; DRUG METABOLISM; HEMODYNAMICS; HUMAN; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; PEDIATRIC ANESTHESIA;

ANESTHETICS, INHALATION; BIOTRANSFORMATION; CHELATING AGENTS; DRUG INTERACTIONS; ETHERS; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; LIVER; METHYL ETHERS; RESPIRATION;

EID: 0029842710     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Eger EI. New inhaled anesthetics Anesthesiology 1994, 80: 906-922.
2. Wallin RF, Regan BM, Napoli MD, Stern IJ Sevoflurane, a new inhalational anesthetic agent Anesth Analg 1975; 54: 758-765.
3. Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane inhuman volunteers. Anesthesiology 1981; 54: 100-106
4. Brown BR Jr Sevoflurane, introduction and overview. Anesth Analg 1995; 81 (Supl): 1-3.
5. Gilsanz F, Roses R, Blanc G, Martín Celemín R, Orts MM Vaporizadores. Act Anest Reanim (Madrid) 1994, 4: 188-202.
6. Frink EJ, Brown BR Jr Sevoflurane. Baillière's Clin Anaesthesiol 1993, 7: 899-913.
7. Brown BR Jr, Frink EJ. Sevoflurane. an update Baillière's Clin Anaesthesiol 1995, 9, 1-14
8. Martin-Larraurt Camarillo R. Farmacocinética del sevoflurano. Act Anest Reanim (Madrid) 1995, 5: 107-111.
9. Gilsanz F, Orts MM. Farmacología clínica del sevoflurano. Act Anest Reanim (Madrid) 1995; 5: 97-106
10. Jones R. Desflurane and sevoflurane: inhalation anaesthetics for this decade Br J Anaesth 1990; 65: 527-536.
11. Lerman J, Sikich N, Kleinman S, Yentis S. The pharmacology of sevoflurane in infants and children. Anesthesiology 1994, 80: 814-824.
12. Lerman J. Sevoflurane in pediatric anesthesia. Anesth Analg 1995; 81 (Supl): 4-10.
13. Carpenter RL, Eger EI II. Alveolar-to-arterial-to venous anesthetic partial pressure differences in humans Anesthesiology 1989, 70 630-635.
14. Eger EI II. Uptake and distribution En: Miller RD, editor Anesthesia. Nueva York: Churchill Livingstone. 1990; 85-104.
15. Yasuda N, Lockhart SH, Eger EI II, Weiskopf RB, Liu J, Laster M et al. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 1991, 72: 316-324.
16. Doi M, Ikeda K. Airway irritation produced by volatile anaesthetics during brief inhalation comparison of halothane, enflurane, isoflurane and sevoflurane. Can J Anaesth 1993, 40: 122-126.
17. Ikeda K, Takasumi K. Pharmacokmetics and pharmacodynamics of new volatile anesthetics. Curr Opin Anaesth 1993, 6 639-643.
18. Eger EI II, Johnson B Rates of awakening from anesthesia with I-653, halothane, isoflurane, and sevoflurane: A test of the effect of anesthetic concentration and duration in rats. Anesth Analg 1987; 66: 977-982.
19. Frink EJ, Malan TP, Atlas M, Domínguez LM, DiNardo JA, Brown BR. Clinical comparison of sevoflurane and isoflurane in healthy patients. Anesth Analg 1992; 74. 241-245.
20. Doi M, Ikeda K. Respiratory effects of sevoflurane Anesth Analg 1987, 66: 241-244.
21. Yamakage M, Kohro S, Kawamata T, Namiki A. Inhibitory effects of four inhaled anesthetics on canine tracheal smooth muscle contractions and intracellular Ca concentration Anesth Analg 1993; 77: 67-72
22. Green W Jr. The venlilatory effects of sevoflurane. Anesth Analg 1995; 81: (Supl): 23-26
23. Ebert TJ, Muzi M, Lopatka CW. The neurocirculatory responses to sevoflurane anesthesia in humans: a comparison to desflurane Anesthesiology 1995; 83. 88-95
24. Kazama T, Ikeda K. The comparative cardiovascular effects of sevoflurane with halothane and isoflurane. J Anesth (Japón) 1988; 2: 63-68.
25. Hayashi Y, Sumikawa K, Tashiro C, Yamatodoni A, Yoshiya I. Arrhythmogenic threshold of epinephrine during sevoflurane, enflurane, and isoflurane anesthesia in dogs. Anesthesiology 1988; 69: 145-147
26. Doi M, Ikeda K Sevoflurane anesthesia with adenosine triphosphate for resection of pheochromocytoma. Anesthesiology 1989, 70: 360-363.
27. Ebert TJ, Harkin CP, Muzi M. Cardiovascular responses to sevoflurane: a review. Anesth Analg 1995, 81 (Supl): 11-22
28. Frink EJ, Morgan SE, Coetzee A, Conzen PF, Brown BR The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs Anesthesiology 1992; 76: 85-90.
29. Brown BR Jr. Hepatotoxicity and inhalation anesthetics: Views in the era of isoflurane. J Clin Anesth 1989, 1: 368-375
30. Frink JE. The hepatic effects of sevoflurane Anesth Analg 1995; 81 (Supl): 46-50.
31. Morgan SE, Frink EJ, Gandolfi AJ. A simplified gas chromatographic method for quantifying the sevoflurane metabolite hexafluoroisopropanol. Anesthesiology 1994, 80 201-205.
32. Gilsanz F Anestésicos inhalatorios en neurocirugía Act Anest Reanim (Madrid) 1994, 4. 164-176.
33. Sugioka S Effects of sevoflurane on intracraneal pressure and formation and absorption of cerebrospinal fluid in cats. Masui 1992; 41: 1.434-1 442
34. Scheller MS, Tateishi A, Drummond JC, Zornow MH The effect of sevoflurane on cerebral blood flow, cerebral metabolic rate for oxygen, intracranial pressure, and electroencephalogram are similar to those of isoflurane in the rabbit. Anesthesiology 1988; 68: 548-551.
35. Takahashi H, Murata K, Ikeda K Sevoflurane does not increase intricraneal pressure in hyperventilated dogs Br J Anaesth 1993, 71 551-555
36. Kitaguchi K, Ohsumi H, Kuro M, Nakajima T, Hayashi Y Effects of sevoflurane on cerebral circulation and metabolism in patients with ischemic cerebrovascular disease. Anesthesiology 1993, 79 704-709.
37. Weisz MT, Jones RM Desflurane: an update. Baillière's Clin Anaesthesiol 1995, 9. 15-35
38. Kharasch ED. Biotransformation of sevoflurane Anesth Analg 1995; 81 (Supl): 27-38.
39. Crandell WB, Pappas SG, Macdonald A. Nephrotoxicity associated with methoxyflurane. Anesthesiology 1988; 27: 591-607.
40. Cousins MJ, Mazze RI. Methoxyflurane nephrotoxicity: a study of dose response in man JAMA 1973; 225: 1.611-1 616
41. Mazze RI. The safety of sevoflurane in humans. Anesthesiology 1992; 77: 1.062-1.064.
42. Malan TP Jr Sevoflurane and renal function. Anesth Analg 1995, 81 (Supl): 39-45
43. Kharasch ED. Inhalation anesthetic toxicity: current controversies. Annual Refresher Course Lectures. Atlanta: ASA, 1995; 264: 1-7
44. Frink EJ, Malan TP, Brown EA, Morgan S, Brown BR. Plasma inorganic fluoride levels with sevoflurane anesthesia in morbidity obese and nonobese patients. Anesth Analg 1993; 76 1 333-1.337
45. Hrguchi H, Satoh T, Arimura S, Kanno M, Endoh R. Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia. Anesth Analg 1993; 77: 1.018-1 021.
46. Mazze RI. Fluorinated anaesthetic nephrotoxicity an update. Can Anaesth Soc J 1984, 31. 516-522.
47. Cousins MJ, Mazze RI, Kosek JC, Hitt BA, Love FV. The etiology of methoxyflurane nephrotoxicity. J Pharm Exp Ther 1974; 190: 530-541.
48. Frink EJ, Brown BR Jr. Sevoflurane. Anesthetic Pharm Rev 1994; 2: 61-67
49. Kobayashi Y, Ochiai R, Takeda J, Sekiguchi H, Fukushima K Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans Anesth Analg 1992; 74: 753-757
50. Bito H, Ikeda K Plasma inorganic fluoride and intracircuit degradation product concentrations in long duration, low-flow sevoflurane anesthesia Anesth Analg 1994; 79: 946-951.
51. Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 1993; 79: 795-807.
52. Kharasch ED, Hankins DC, Thummel KE, Anderson T Kidney methoxyflurane and sevoflurane metabolism: intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 1995; 82: 689-699.
53. Bito H, Ikeda K Closed circuit anesthesia with sevoflurane in humans Anesthesiology 1994, 80 71-76
54. Bito H, Ikeda K Degradation products of sevoflurane during low flow anaesthesia. Br J Anaesth 1995, 74: 56-59
55. Gilsanz F, Martín Cabello A, Orts MM, Sevoflurano. Act Anest Reanim (Madrid) 1994, 4. 117-119
56. Hanaki C, Fujii K, Mono M, Tashinao T. Decomposition of sevoflurane in soda lime Hiroshima J Med Sci 1987; 36: 61-67.
57. Sharp JH, Trudell JR, Cohen EN Volatile metabolites and decomposition products of halothane in man Anesthesiology 1979; 50: 2-8.
58. Dekant W, Vamvakas S, Anders MW. Formation and fate of nephrotoxic and cylotoxic glutathione S-conjugates: cysteine conjugate beta-lyase pathway. Adv Pharmacol 1994; 27: 117-163.
59. Finkelstein MB, Vamvakas S, Bittner D, Anders MW. Structure-mutagenicity and structure-cytotoxicity studies on bromine-containing cysteine S-conjugates and related compounds Chem Res Toxicol 1994; 7: 157-163
60. 2 absorbents during low-flow anesthesia in surgical patients. Anesthesiology 1992, 77 1 064-1.069.
61. Liu J, Laster MJ, Eger EI II, Taheri S. Absorption and degradation of sevoflurane and isoflurane in a conventional anesthetic circuit. Anesth Analg 1991, 72: 785-789
62. Callan CM. Is there equivalence between compaund A and a synthetic olefin? Anesthesiology 1994; 81. 272
63. Gonsowski CT, Laster MJ, Eger EI II, Ferrell LD, Kerschman RL Toxicity of compound A in rats: effects of a 3-hour administration Anesthesiology 1994, 80 556-565.
64. Gonsowski CT, Laster MJ, Eger EI II, Ferrell LD, Kerschmann RL. Toxicity of compound A in rats, effects of increasing duration of administration Anesthesiology 1994, 80: 566-573.
65. Callan C, Prokocimer P, Delgado-Herrera L, Friedman M, Keller K Effect of compound A on the kidney of Sprague-Dawley rats. Anesthesiology 1994, 78 (Supl): 41.
66. Kenna JG, Jones RM. The organ toxicity of inhaled anesthetics Anesth Analg 1995, 81 (Supl) 51-66.
67. Kobayashi O, Ohta Y, Kosaka F. Interaction of sevoflurane, isoflurane, enflurane and halothane with nondepolarizing muscle relaxants and their prejunctional effects at the prejunctional effects at the neuromuscular junction. Acta Med Okayama 1990; 44: 209-215.
68. Dale O. Drug interactions in anaesthesia focus of desflyrane and sevoflurane. Baillière's Clin Anaesthesiol 1995; 9: 105-117.
69. Otsuja H, Komura Y, Mayumi T, Yamamura T, Kemmotsu O, Mukaida K Malignant hyperthermia during sevoflurane anesthesia in a child with central core disease. Anesthesiology 1991; 75: 699-701.
70. Ochiai R, Toyoda Y, Nishio I, Takeda J, Sekiguchi H, Fukushima K et al Possible association of malignant hyperthermia with sevoflurane anesthesia Anesth Analg 1992, 74: 616-618.
71. Jones R. Desflurane and sevoflurane: inhalation anaesthetics for this decade Br J Anaesth 1990, 65: 527-536.
72. Lerman J. Sevoflurane in pediatric anesthesia Anesth Analg 1995; 81 (Supl): 4-10.
73. Quinn AC, Newman PJ, Hall GM, Grounds RM Sevoflurane anaesthesia for major intraabdominal surgery. Anaesthesia 1994; 49: 567-571
74. Smith I, Nathanson MH, White PF. The role of sevoflurane in outpatient anesthesia Anesth Analg 1995; 81 (Supl): 67-72
75. Smith I, Nathanson M, White PF. Sevoflurane - a long awaited volatile anaesthetic. Br J Anaesth 1996; 76: 435-445